2013 News Releases

Keyword Search
 
2013 | 2012 | 2011 | 2010 | 2009
DateTitle 
05/13/13Covidien Announces Senior Notes OfferingPrinter Friendly Version
05/13/13Covidien Announces Pricing of $750 Million Senior Notes OfferingPrinter Friendly Version
05/08/13Covidien and Mallinckrodt to Present at Bank of America Merrill Lynch ConferencePrinter Friendly Version
05/06/13Covidien Appoints Jacqueline Strayer Senior Vice President, Corporate CommunicationsPrinter Friendly Version
05/03/13Covidien Announces First Full-Year Outlook for Mallinckrodt plcPrinter Friendly Version
05/03/13Covidien Announces 2013 Guidance and Provides Historical Financial Statements Adjusted for Discontinued OperationsPrinter Friendly Version
04/29/13Covidien Notification of Stolen Product - Single Lot of Non-Sterile Endo GIA ArticulatingTM 60 3.5mm Single Use Loading UnitPrinter Friendly Version
04/26/13Covidien Reports Second-Quarter ResultsPrinter Friendly Version
04/17/13Covidien Introduces New Surgical Access Devices at SAGES 2013Printer Friendly Version
04/15/13Covidien Launches New Shiley™ Neonatal and Pediatric Tracheostomy TubesPrinter Friendly Version
04/11/13Covidien and VIDA Diagnostics Collaborate to Expand Minimally Invasive Treatment of Lung DiseasePrinter Friendly Version
04/08/13Mallinckrodt International Finance S.A. Announces Private Offering of Senior Unsecured NotesPrinter Friendly Version
04/08/13Mallinckrodt International Finance S.A. Announces Pricing of Senior Unsecured Notes OfferingPrinter Friendly Version
03/29/13Covidien Awarded $176.5 Million Verdict in Patent Litigation against Ethicon Endo-SurgeryPrinter Friendly Version
03/25/13Mallinckrodt Launches Additional Dosage Strengths of Generic CONCERTA® in U.S.Printer Friendly Version
03/21/13Covidien Expands Share Repurchase Program and Declares Quarterly Cash DividendPrinter Friendly Version
03/20/13Covidien Announces Results from 2013 Annual General MeetingPrinter Friendly Version
03/15/13Covidien Announces Nominees to Board of Directors for Mallinckrodt Pharmaceutical BusinessPrinter Friendly Version
03/14/13Covidien plc to Report Second-Quarter Results on April 26, 2013Printer Friendly Version
03/13/13Covidien Launches Three New Hernia Care Products at American Hernia Society Annual MeetingPrinter Friendly Version
03/07/13Covidien to Present at Barclays ConferencePrinter Friendly Version
02/25/13Covidien to Present at Raymond James ConferencePrinter Friendly Version
02/20/13Covidien Completes Patient Enrollment in Iliac Stent Clinical Study SeriesPrinter Friendly Version
02/19/13Covidien to Present at Upcoming Investor ConferencesPrinter Friendly Version
02/07/13Two-Year Clinical Study Supports Safety and Efficacy of Covidien Solitaire™ FR Revascularization DevicePrinter Friendly Version
02/05/13Covidien Announces Continued Relationship with NYSE EuronextPrinter Friendly Version
02/01/13Covidien Announces Filing of Form 10 Registration Statement in Connection with Planned Spin-Off of Pharmaceuticals BusinessPrinter Friendly Version
01/25/13Covidien Reports First-Quarter ResultsPrinter Friendly Version
01/23/13Covidien Receives CE Mark Approval for EverFlex™ Self-expanding Peripheral Stent with Entrust™ Delivery SystemPrinter Friendly Version
01/21/13Mallinckrodt Announces Approval of New Gablofen® Prefilled SyringePrinter Friendly Version
01/17/13Living Heart Foundation Launches HOPE Program for Former NFL PlayersPrinter Friendly Version
01/16/13Covidien Announces Launch of Therapeutic Device for Treatment of Resistant HypertensionPrinter Friendly Version
01/15/13Covidien Completes Enrollment in the DEFINITIVE AR StudyPrinter Friendly Version
01/14/13Covidien Opens Patient Enrollment for SWIFT PRIME Acute Ischemic Stroke StudyPrinter Friendly Version
01/10/13Covidien Completes Acquisition of CV IngenuityPrinter Friendly Version
01/07/13Covidien’s Tri-Staple™ Technology Platform Reaches $1 Billion Sales MilestonePrinter Friendly Version

Stock Quote

COV (Common Stock)
ExchangeNYSE
 (US Dollar)
Price$65.77
Change (%) Stock is Up 0.10
 (0.15%)
Volume2,652,403
As of 05/17/13 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Tool Kit

Printer Friendly Version    Printer-friendly version
E-mail this page   E-mail this page
RSS    RSS Feeds
E-mail Alerts Receive E-mail Alerts
View contacts     View contacts